Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

2.

A role for VASP in RhoA-Diaphanous signalling to actin dynamics and SRF activity.

Grosse R, Copeland JW, Newsome TP, Way M, Treisman R.

EMBO J. 2003 Jun 16;22(12):3050-61.

3.

LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics.

Geneste O, Copeland JW, Treisman R.

J Cell Biol. 2002 May 27;157(5):831-8. Epub 2002 May 28.

4.

Homo-oligomerization is essential for F-actin assembly by the formin family FH2 domain.

Copeland JW, Copeland SJ, Treisman R.

J Biol Chem. 2004 Nov 26;279(48):50250-6. Epub 2004 Sep 14.

5.

Functional interactions between phosphatase POPX2 and mDia modulate RhoA pathways.

Xie Y, Tan EJ, Wee S, Manser E, Lim L, Koh CG.

J Cell Sci. 2008 Feb 15;121(Pt 4):514-21. doi: 10.1242/jcs.013557. Epub 2008 Jan 29.

6.

The RhoA effector mDiaphanous regulates MyoD expression and cell cycle progression via SRF-dependent and SRF-independent pathways.

Gopinath SD, Narumiya S, Dhawan J.

J Cell Sci. 2007 Sep 1;120(Pt 17):3086-98. Epub 2007 Aug 7.

8.

Signal-regulated activation of serum response factor is mediated by changes in actin dynamics.

Sotiropoulos A, Gineitis D, Copeland J, Treisman R.

Cell. 1999 Jul 23;98(2):159-69.

9.

The RhoA-binding protein, rhophilin-2, regulates actin cytoskeleton organization.

Peck JW, Oberst M, Bouker KB, Bowden E, Burbelo PD.

J Biol Chem. 2002 Nov 15;277(46):43924-32. Epub 2002 Sep 6.

10.

Actin dynamics control SRF activity by regulation of its coactivator MAL.

Miralles F, Posern G, Zaromytidou AI, Treisman R.

Cell. 2003 May 2;113(3):329-42.

11.

Biochemical characterization of the Rho GTPase-regulated actin assembly by diaphanous-related formins, mDia1 and Daam1, in platelets.

Higashi T, Ikeda T, Shirakawa R, Kondo H, Kawato M, Horiguchi M, Okuda T, Okawa K, Fukai S, Nureki O, Kita T, Horiuchi H.

J Biol Chem. 2008 Mar 28;283(13):8746-55. doi: 10.1074/jbc.M707839200. Epub 2008 Jan 24.

12.
13.

Actin filament bundling and different nucleating effects of mouse Diaphanous-related formin FH2 domains on actin/ADF and actin/cofilin complexes.

Machaidze G, Sokoll A, Shimada A, Lustig A, Mazur A, Wittinghofer A, Aebi U, Mannherz HG.

J Mol Biol. 2010 Nov 5;403(4):529-45. doi: 10.1016/j.jmb.2010.09.017. Epub 2010 Oct 1.

PMID:
20869367
14.

[Serum response factor participates in RhoA-induced endothelial cell F-actin rearrangements].

Han YL, Yu HB, Yan CH, Meng ZM, Zhang XL, Kang J, Li SH, Wang SW.

Sheng Li Xue Bao. 2005 Jun 25;57(3):295-302. Chinese.

15.

Muscle-specific signaling mechanism that links actin dynamics to serum response factor.

Kuwahara K, Barrientos T, Pipes GC, Li S, Olson EN.

Mol Cell Biol. 2005 Apr;25(8):3173-81.

16.

Differential usage of signal transduction pathways defines two types of serum response factor target gene.

Gineitis D, Treisman R.

J Biol Chem. 2001 Jul 6;276(27):24531-9. Epub 2001 May 7.

17.

Coordination of microtubules and the actin cytoskeleton by the Rho effector mDia1.

Ishizaki T, Morishima Y, Okamoto M, Furuyashiki T, Kato T, Narumiya S.

Nat Cell Biol. 2001 Jan;3(1):8-14.

PMID:
11146620
18.

High activity of serum response factor in the mesenchymal transition of epithelial tumor cells is regulated by RhoA signaling.

Psichari E, Balmain A, Plows D, Zoumpourlis V, Pintzas A.

J Biol Chem. 2002 Aug 16;277(33):29490-5. Epub 2002 May 30.

19.

Dissecting requirements for auto-inhibition of actin nucleation by the formin, mDia1.

Li F, Higgs HN.

J Biol Chem. 2005 Feb 25;280(8):6986-92. Epub 2004 Dec 9.

20.

Inhibition of RhoA-mediated SRF activation by p116Rip.

Mulder J, Ariaens A, van Horck FP, Moolenaar WH.

FEBS Lett. 2005 Nov 7;579(27):6121-7. Epub 2005 Oct 13.

Supplemental Content

Support Center